OssDsign Revenue and Competitors

Uppsala,

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • OssDsign's estimated annual revenue is currently $8.9M per year.(i)
  • OssDsign's estimated revenue per employee is $153,000

Employee Data

  • OssDsign has 58 Employees.(i)
  • OssDsign grew their employee count by -5% last year.

OssDsign's People

NameTitleEmail/Phone
1
VP Sales, USReveal Email/Phone
2
VP SalesReveal Email/Phone
3
Global Marketing DirectorReveal Email/Phone
4
Director Quality AssuranceReveal Email/Phone
5
Regional Manager MidwestReveal Email/Phone
6
Area Sales Director- OssDsignReveal Email/Phone
7
Cranial Sales Manager, EastReveal Email/Phone
8
Mid-Atlantic Regional Sales Manger & Government Sales ManagerReveal Email/Phone
9
ValideringsingenjörReveal Email/Phone
10
Marketing AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.4M114-37%N/AN/A
#2
$1.1M110%N/AN/A
#3
$5.6M41N/AN/AN/A
#4
$5780M77268%N/AN/A
#5
$9.9M655%N/AN/A
#6
$41.7M22324%N/AN/A
#7
$24270M2786321%$4BN/A
#8
$207.3M871N/AN/AN/A
#9
$4M528%N/AN/A
#10
$4.2M31N/AN/AN/A
Add Company

What Is OssDsign?

OssDsign is a Swedish medtech company dedicated to creating regenerative implants for improved healing of bone defects. We provide surgeons and patients around the world with an expanding range of innovative implant solutions for improved patient outcomes. OssDsign's technology is the result of collaboration between clinical researchers at the Karolinska University Hospital, Stockholm, and material science experts at the Ångström Laboratory at Uppsala University. In November 2020, OssDsign acquired Sirakoss, a Scottish company dedicated to developing the next generation nanosynthetic bonegraft substitute. Website: www.ossdsign.com Newsroom: https://news.cision.com/ossdsign-ab (Always consult Instructions for Use which accompany the products for complete indications, contraindications, warnings and precautions.)

keywords:N/A

N/A

Total Funding

58

Number of Employees

$8.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OssDsign News

2022-04-19 - Karolinska Development's portfolio company OssDsign completes ...

STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign...

2022-03-30 - Karolinska Development's portfolio company OssDsign enrolls the ...

STOCKHOLM, SWEDEN, April 4, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has...

2022-03-30 - Karolinska Development's portfolio company OssDsign enrolls the ...

OssDsign has initiated a patient registry for spinal fusion that ... with the company's nanosynthetic bone graft, OssDsign Catalyst.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.7M59-8%N/A
#2
N/A6329%N/A
#3
N/A6423%N/A
#4
$10.1M65-16%N/A
#5
$9.8M754%N/A